Decreased IL-2 responses in ICL. by Florence Bugault (278171)

Decreased IL-7 responses in ICL. by Florence Bugault (278171)

“…(B) Example of decreased pSTAT5 response to IL-7 stimulation in memory CD4⁺ T cells from ICL patient P3. …”

Bioluminescence decreases with aging in transgenic mice. by Sarah E. Mailhiot (766685)

Cholesterol oxidation decreases membrane order. by Maarit Neuvonen (195662)

CDA-2 decreases pulmonary inflammation. by Xuan Wang (55634)

Decreased immunofluorescence during multiplex staining. by Sandrine Prost (38667)

“…<p>Serial sections were stained with 1 to 5 different markers (Marker 1, MHCII Qdot 705Vivid; Marker 2, HO1 Qdot 605Vivid; Marker 3, CD163 Qdot 565; Marker 4, CD206 Qdot 655Vivid; Marker 5, CD68 streptavidin Qdot 525). …”

MVK activates microglia and decreases phagocytosis. by Ren Y. Sato (16914027)

βL decreases body mass. by Jeong-sook Lee (127654)

Foxa1 decreases FA uptake. by Marta Moya (188959)

SAA decreases the expression of adipocyte markers. by Aurélie Faty (169741)

Decreased expression of DCX in the infected brain. by Manohar B. Mutnal (233165)

AICD transgenic mice show decreased cell proliferation in the SGZ of hippocampus. by Kaushik Ghosal (244754)

“…<p>Representative images of BrdU immunostaining in the subgranular zone (SGZ) of the dentate gyrus performed on 1.5-mont-old (<b>A</b>) 3-month-old (<b>C</b>) and 12-month old (<b>D</b>) wild-type and FeCγ25 animals one day after the final BrdU injection (100 mg/kg). …”

At lower concentrations, METH decreases LTP. by Jarod Swant (246454)

“…At 0.1 µM METH, LTP was 1.58±.08 [<i>n</i> = 13(5)] (Fig. 1B); at 1 µM METH, LTP was 1.50±.07 [<i>n</i> = 13(7)] (Fig. 1C); at 10 µM METH, LTP was 1.58±.07 [<i>n</i> = 14(8)] (Fig. 1D); at 30 µM METH, LTP was 1.37±.06 [<i>n</i> = 15(4)] (Fig. 1E); and at 60 µM METH, LTP was 1.32±.24 [<i>n</i> = 4(2)] (Fig. 1E). …”

Norepinephrine clearance is decreased in the hypoperfused kidney. by Rong Gu (231159)

SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

“…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”

AHCC decreases survival of AML cells. by Kavin Fatehchand (4262467)

Nanoparticle formulation decreases curcumin cytotoxicity. by Upendhar Gandapu (208623)

Pharmacological inhibition of EGFR decreases reduces a subset of the inflammatory response at day 2 post-infection. by Marc Swidergall (185453)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)